Introduction
Thymidylate synthase (TS) is an essential enzyme in proliferating cells and an important target for a variety of anticancer drugs. This enzyme is responsible for catalyzing the de novo biosynthesis of thymidylate, which is necessary for DNA synthesis and repair. The mechanism involves the reductive transfer of a methylene group from the cofactor, 5, 10-methylene-tetrahydrofolate (CH 2 H 4 folate), to the 5 position of the substrate, 2'-deoxyuridine 5'-monophosphate (dUMP), to form 2'-deoxythymidine 5'-monophosphate (dTMP).
Many TS analogs of both the substrate, dUMP, and the cofactor, CH 2 H 4 folate, have been synthesized and investigated as potential anticancer therapeutics. Two clinically useful substrate analogs are 5-fluorouracil (5-FU) and fluorodeoxyuridine (FdUrd), which are metabolized in vivo to 5-fluoro-2-deoxyuridylate (FdUMP). FdUMP acts as an inhibitor of TS by forming a stable ternary complex with TS and the folate cofactor, resulting in inhibition of enzyme function. In addition to these substrate analogs, novel folate cofactor analogs, such as raltitrexed (Tomudex) and thymitaq have also been designed as specific inhibitors of TS activity (1a) .
To better understand the mechanism of TS enzyme catalysis, several laboratories have correlated TS enzyme structure and activity using mutagenesis. Following substitution of different amino acids at random or specific points within the enzyme, enzyme activity and affinity for inhibitors are measured to determine how a particular residue(s) contributes to the overall mechanism. Recently, several mutations at highly conserved active site residues have been made for human TS (hTS) residue acts as a bridge linking the enzyme C terminus, substrate, and cofactor together and plays an important role in the enzyme's mechanism of action by binding to the phosphate group of dUMP (4).
To examine the hypothesis that the reduced affinity of G52S for Thymitaq and FdUMP is a result of impaired movement of the Arg 50 loop and to investigate further the Arg-FdUMP interaction, this study applied ab initio (Hartree-Fock) and semiempirical calculations to the system.
Methods and Results

Interactions Between the Methylguanidinium Ion as a Model for the Arg 50 Residue and the Phosphate Group as a Model for FdUMP in TS
The Gaussian 98 computer program (5) was used to perform ab initio calculations at HF/6-311G* (Hartree-Fock) and at MP2/6-311G* level to investigate the interaction between the methylguanidinium ion as a model for the Arg 50 residue in thymidylate synthase, and a phosphate group as a model for the inhibitor FdUMP. The 6-311G* basis set involves one Slater orbital for the description of core electrons and three Slater orbitals for the description of valence electrons, one expanded in a series of three gaussians and the other two approximated by one gaussian each. In addition, d functions are set on the non-hydrogen atoms. The correlation energy is included in the calculations via the use of the Moller-Plesset perturbation theory, with the second-order term, MP2, applied to all electrons. The two systems considered are a. Complex 1a-the complex formed by methylguanidine and the negative methyl phosphate ion (Fig. 1A) , and b. Complex 1b-the complex formed by the methylguanidinium ion with the binegatively charged methyl phosphate ion (Fig. 1B) .
The energies of the complexes and of the subsystems, as obtained via geometry optimization, are shown in Table 1 . Table 2 shows the optimized parameters of the complexes. tripeptides are geometry optimized using the 6-31G* basis set at Hartree-Fock level, as implemented by the PC Spartan program (6) . Figure 2A shows the optimized Arg Figure 5 shows the loop as part of rat thymidylate synthase complexed with dUMP and the anticancer drug raltitrexed (Tomudex) (7).
Comparison of the Structures of the
timized with the MNDO semi-empirical method and modeled using the Insight II program on a Silicon Graphics station. The same procedure was used for the loop with Gly 52 replaced by a Ser residue. The superimposed peptides of the Arg 50 loop are shown in Figure 3 . Figure 4 shows the superimposition of 
Discussion
The complex formed by the negative methylphosphate and methylmethylguanidine (Complex 1a; Fig. 1A ) is more stable than the one formed by the methylmethylguanidinium ion and the binegative methylphosphate ion (Complex 1b; Fig. 1B) , by 31.80 kcal/mol at HF/6-311G*//MP2 (full)/6-311G* level and by 31.64 kcal/mol at MP2 (full)/6-311G* level. This is not surprising: the proton affinity of methylguanine is only 257.38 kcal/mol at HF/6-311G*//MP2 (full)/6-311G* level and 248.41 kcal/mol at MP2 (full)/6-311G* level, whereas the proton affinity of the binegative methylphosphate ion is 473.29 kcal/mol at HF/6-311G*//MP2(full)/ 6-311G* level and 468.58 kcal/mol at MP2 (full)/6-311G* level. On the other hand, complex 1b features a much larger binding energy due to the electrostatic attraction between opposite charges, in addition to the hydrogen binding. Indeed, the binding of complex 1a is 16.40 kcal/mol at HG/6-311G*//MP2 (full)/6-311G* level and 20.12 kcal/mol at MP2 (full)/6-311G* level, while the binding energies of complex 1b are 200.51 kcal/mol and 208.64 kcal/mol, respectively; these energies include an electrostatic interaction between a positive and a negative charge.
Complex 1a was optimized by allowing the methylguanidine moiety to relax into a nonplanar conformation, similar to methylguanidine itself. Indeed, if methylguanidine is optimized using a small basis set, without energy terms, it adopts a quasi-planar geometry. However, when large basis sets such as 6-311G* are used, methylguanidine features the hydrogens out of the plane of the carbon and the three nitrogens. On the contrary, the guanidium ion is always planar, due to the Y aromaticity. As a consequence, when the methylguanidine moiety is forced to stay planar, the most stable complex features a hydrogen bond between H1 (placed on the oxygen O1) and the nitrogen atom N1, on which there is only one hydrogen. This complex has a binding energy about half of the complex 1a, which features one of the hydrogens set on nitrogen N2 hydrogen bound to O2, at a distance of 1.88 Å. It may be concluded that the strongest phosphatemethylguanidine interaction occurs via the hydrogen bond formed by one of the hydrogens set on a nitrogen and an oxygen of the phosphate ion. As shown before, this complex is more stable than complex 1b.
As seen from Figure 2C , the HF/6-31G* optimization of the Arg 50 -Thr 51 -Gly 52 and the Arg 50 -Thr 51 -Ser 52 predicts a significant displacement of the Arg 50 residue when Gly 52 is replaced by Ser. The difference in the geometries of the two tripeptides might be attributed to electrostatic effects introduced by the presence of the electronegative oxygen present in serine.
When the whole Arg 50 loop is optimized with the MNDO method, as seen in Figure 3 , the displacement of Arg 50 is seen even more. This displacement is also observed in Figure 4 , which shows the MNDO optimization of the two tripeptides.
In conclusion, our calculations of the interaction between the methylguanidinium ion as a model for the Arg 50 residue and the phosphate group as a model for FdUMP in TS predict a significant displacement of the Arg 50 residue upon mutation of Gly 52 to Ser. It is possible that this displacement could result in impaired movement of the entire Arg 50 loop, accounting for loss of binding of FdUMP.
Because loss of binding is not seen with the natural substrate, dUMP, it is suggested that the presence of the fluorine on FdUMP may influence the flexibility of the phosphate group. 
